Teva nears restart of CA plant; Packaging miscommunication has big price;

> Teva expects to restart production at its Irvine, CA, plant next month, following a remediation effort prompted by a December 2009 warning letter. Story

> Life sciences artwork management firm Kallik says that human error and incomplete product data have a big effect on production; poor coordination between the creative and technical sides of the house lengthens review cycles and generates unnecessary rework. Article

> An RFID pilot for track and trace at the item, pack and pallet level has been completed by Argentinean drugmaker Laboratorios Gador. Story

> CMO ScinoPharm in Taiwan will make vilazodone hydrochloride, the active ingredient in Clinical Data's just approved antidepressant, Viibryd. Item

> High tech electronics may provide a role model for the biopharma supply chain. Column

> The U.S. Trade and Development Agency is organizing a two-week trade mission to connect Indian drug executives and officials with U.S. cold chain suppliers and manufacturers. Article

> Contract manufacturer Helix plans to begin construction of a manufacturing plant in Costa Rica. Story

> Felten has designed and built a manufacturing facility for Czech-based Lonza Biotec, boosting fermentation capacities by 50 percent. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.